n-methylbenzamide

N-Methylbenzamide is a potent inhibitor of phosphodiesterase 10A (PDE10A) with demonstrated anti-cancer activity.

4-chloro-N-MethylbenzaMide, with CAS No. 6873-44-5, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. 4-chloro-N-MethylbenzaMide provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

AP-065/13116303 is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. AP-065/13116303 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

4-((2-Cyanopropan-2-yl)amino)-2-fluoro-N-methylbenzamide is a pharmaceutical intermediate employed in the synthesis of various active compounds.

N-cyclopropyl-3-fluoro-4-methylbenzamide, with CAS No. 1090936-90-5, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. N-cyclopropyl-3-fluoro-4-methylbenzamide provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

CHEMBL1276927 (N-(3-(1H-benzo[d]imidazol-2-yl)phenyl)-3-methylbenzamide) shows antibacterial and antiparasitic activities against Chlamydia pneumoniae and Leishmania donovani.

EZH2 IN 200 (Compound 200) is a chemical intermediate utilized in the synthesis of various active compounds.

Zegocractin (CM-4620) is an inhibitor of calcium-release activated calcium (CRAC) channels.